Page last updated: 2024-10-19

hydroxide ion and Arthritis, Rheumatoid

hydroxide ion has been researched along with Arthritis, Rheumatoid in 1 studies

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research Excerpts

ExcerptRelevanceReference
"To reduce the side effects of methotrexate and increase its anti-inflammatory effect, we developed a drug delivery system, dextran sulfate-modified methotrexate-loaded layered double hydroxide nanocomposites (LDH-MTX-DS), with both targeting and pH-sensitivity for the treatment of rheumatoid arthritis."4.02Dextran sulfate-modified pH-sensitive layered double hydroxide nanocomposites for treatment of rheumatoid arthritis. ( Su, M; Wang, X; Xi, M; Xu, X; Yang, B; Yin, Z, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, X1
Yang, B1
Xu, X1
Su, M1
Xi, M1
Yin, Z1

Other Studies

1 other study available for hydroxide ion and Arthritis, Rheumatoid

ArticleYear
Dextran sulfate-modified pH-sensitive layered double hydroxide nanocomposites for treatment of rheumatoid arthritis.
    Drug delivery and translational research, 2021, Volume: 11, Issue:3

    Topics: Animals; Arthritis, Rheumatoid; Dextran Sulfate; Hydrogen-Ion Concentration; Hydroxides; Methotrexat

2021